Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

Total article views   HTML views PDF downloads Totals
8,050 Dovepress* 6,608+ 1,697 8,305
PubMed Central* 1,442 508 1,950
Totals 8,050 2,205 10,255
*Since 24 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 1 4

View citations on PubMed Central and Google Scholar